Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Scopoderm 1.5mg Patch
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Hyoscine may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
What it is and what it is used for
for Scopoderm 1.5mg Patches contain the active substance hyoscine which belongs to the group of medicines called anti-emetics or anti-sickness medicines. They are used to prevent the symptoms of motion sickness such as nausea (feeling sick), vomiting (being sick) and vertigo (loss of balance), which can occur when travelling by boat, train or car. Travel sickness occurs when your body's internal balancing system becomes confused by receiving different messages – your eyes say one thing about the position of your body, but your balance mechanisms tell you differently. Anyone can suffer from travel sickness: children are more prone but often grow out of it as they get older.
What you need to know before you take it
e Scopoderm 1.5mg Patches Do not use Scopoderm 1.5mg Patches if you:
- have glaucoma or a history of glaucoma (pressure behind the eye)
- are allergic (hypersensitive) to hyoscine or any of the other ingredients in the patch (see Section 6). Warnings and precautions Talk to you doctor or pharmacist before using Scopoderm 1.5mg Patches if you:
- suffer from pyloric stenosis (a condition which affects your stomach)
- have problems urinating – for example due to a bladder obstruction or diseases of the prostate
- have a blockage of your intestines
- are an elderly patient or have any metabolic, liver or kidney disease
- suffer from epilepsy (increased number of fits have been reported)
- have had pain in the eyes, blurred vision, or see rainbowcoloured halos around light. (Scopoderm 1.5mg Patches should only be used after an eye examination by a doctor). Care should be taken after removal of the patch as side effects may persist for up to 24 hours or longer under these circumstances, Scopoderm 1.5mg patches may be unsuitable for you.
- antidepressants
- antiparkinsons and antivirals
- antiarrhythmics
- other travel sickness medicines. Scopoderm 1.5mg Patches with food, drink and alcohol Do not drink alcohol whilst using the patches or until the effects of the patches have worn off (this may last up to 24 hours or longer from the time you have removed it). Pregnancy and breast-feeding If you are pregnant or breastfeeding, you should talk to your doctor. Do not use during pregnancy and breast-feeding unless your doctor advises you to. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines Scopoderm 1.5mg Patches may make you feel drowsy, confused, or dizzy and may affect your vision. Do not drive, operate any machinery, or perform any activity that requires concentration or engage in any other activities in which such symptoms could be dangerous (see possible side-effects). Care should be taken after removal of the patch as these effects may persist for up to 24 hours or longer.
How to take it
Scopoderm 1.5mg Patches Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Do not exceed the recommended dose. Adults and the elderly One patch should be applied about 5-6 hours before leaving on your journey (or the evening before) to a clean, dry, hairless area of intact skin behind the ear. 1. Remove the patch from the sachet. Peel off the clear, hexagonal plastic backing, holding the patch by its edge so as not to touch the sticky side (Figure 1). 2. Press the silver coloured sticky side of the patch firmly on to a clean, dry, hairless area of skin behind the ear (Figure 2). Avoid areas of skin that are cut or irritated in any way. 3. Wash your hands thoroughly after applying the patch. Do not touch the patch once it is in place as you may get the active ingredient on your fingers. If you do touch the patch, wash your hands immediately. Do not get the active ingredient near your eyes. If you get hyoscine on your fingers then touch your eyes, your vision may be temporarily affected. 4. Once your journey is over, take the patch off and dispose of it carefully. 5. When you take a patch off wash your hands and also the area of skin where the patch has been.
Use in the elderly If you are elderly, you may be more prone to suffer from the sideeffects of hyoscine (see Section 4: Possible Side Effects). Use in children Can be used in children aged 10 years or over (see dosage for adults). The use of these patches is not recommended in younger children. See your doctor or pharmacist for alternative medicines. If you use more Scopoderm 1.5mg Patches than you should If you accidentally use too many patches, you may feel restless, excited or confused. In cases of higher overdose, you may become
disorientated, hallucinate or have fits. In severe cases of overdose, coma and breathing difficulties may occur. Remove the patch / patches immediately, and tell your doctor or go to your nearest casualty department immediately. Take any remaining patches with you. If you experience a rise in body temperature after using the Scopoderm Patch you should take immediate action to lower body temperature in addition to seeking medical help and removing the patch. If you forget to use Scopoderm 1.5mg Patches If you forget to put a patch on, apply it as soon as you remember. Do not apply two patches at once to make up for the one that you forgot. If you stop using Scopoderm 1.5mg Patches In rare cases – usually after several days of use – symptoms such as dizziness, nausea (feeling sick), vomiting (being sick), headache and disturbances of balance have been reported after discontinuation of the treatment. These symptoms are more likely to occur if you have been wearing a patch for several days. If you are affected in this way, avoid any activities requiring concentration, e.g. driving, or operating machinery, until your symptoms have worn off and consult a doctor. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Possible side effects
Like all medicines, Scopoderm 1.5mg Patches can cause side effects, although not everybody gets them. STOP using Scopoderm 1.5mg and seek medical help immediately if you or your child has any of the following which may be signs of an allergic reaction:
- Difficulty in breathing or swallowing
- Swelling of the face, lips, tongue or throat
- Severe itching of the skin, with a red rash or raised bumps Some side effects could be serious which are very rare (may affect 1 in every 10,000 people)
- Changes in vision with increased pressure in the eye (possible signs of glaucoma). If you experience this, tell your doctor straight away. Some side effects are very common (may affect more than 1 in 10 people)
- Dryness of the mouth.
- Drowsiness, dizziness
- Frequently blurring of (near) vision and enlargement of the pupils (sometimes in one eye only),
- Loss of ability to focus on close or far objects (visual accommodation) Some side effects are common (may affect between 1 and 10 in every 100 people)
- Irritation of the eyelids
- Skin irritation
Some side effects are rare (may affect between 1 and 10 in every 1,000 people)
- Difficulty in passing water (urinating)
- Impairment of memory or concentration, restlessness, disorientation, confusion, or hallucinations.
31054602
Each patch will last for up to 3 days. If you are travelling for more than three days, take the patch off after 3 days and apply a fresh patch behind the other ear. You can swim, bathe or shower with little risk of the patch coming off, provided that you have applied the patch properly. However, it is best not to stay in the water too long. If the patch accidentally comes off, dispose of it carefully and put on a new patch.
Some side effects are very rare (may affect less than 1 in every 10,000 people)
- Skin rash There are some side effects with not known frequency (frequency cannot be estimated from the available data)
- Agitation, co-ordination abnormalities, headache
- Increase in body temperature
- Reactions at the application site such as rash, itching, redness and burning. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in
the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
How to store it
Scopoderm 1.5mg Patches
- Keep this medicine out of the sight and reach of children.
- Store below 25°C.
- Do not remove from the protective pouch until you need it.
- Do not use Scopoderm 1.5mg Patches after the 'Use by' date which is stated on the carton and pouch. The 'Use by' date refers to the last day of that month. The transdermal patch should be folded in half (sticky side inwards) before being discarded. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
Contents of the pack and other information
What Scopoderm 1.5mg Patches contain The active ingredient in each patch is hyoscine 1.5mg (the average amount of hyoscine absorbed from each patch in 72 hours is 1mg). The other ingredients are light mineral oil, polyisobutylene and polypropylene. What Scopoderm 1.5mg Patches look like and contents of the pack Scopoderm 1.5mg Patches are flat, round patches approximately 1.8 cm in diameter. One side of the patch is tan; the other side is silver and is placed on an oversized clear hexagonal film. Each patch is individually packed into a foil pouch. Each cardboard carton contains two patches. Marketing Authorisation Holder Baxter Healthcare Ltd. Caxton Way, Thetford, Norfolk, IP24 3SE, United Kingdom Manufacturer Famar A.V.E. AVLON PLANT 48th Km National Road, Athens-Lamia Avlonas, 19011, Attiki, Greece For any information about this medicinal product, please contact the Marketing Authorisation Holder. This leaflet was last revised in June 2024
31054602 0719006824
Frequently asked questions about Scopoderm 1.5mg Patch
How do I take Scopoderm 1.5mg Patch?
Scopoderm 1.5mg Patch comes as patch containing 1.5mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Scopoderm 1.5mg Patch?
The active substance in Scopoderm 1.5mg Patch is hyoscine.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Scopoderm 1.5mg Patch, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Scopoderm 1.5mg Patch without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: hyoscine
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
For the prevention of travel sickness symptoms e.g. nausea, vomiting and vertigo.
4.2. Posology and method of administration
Posology
Adults
To achieve the optimum protective effect, Scopoderm Patch should be applied about 5-6 hours before embarking on a journey (or on the evening before the journey). The system should be placed onto a clean, dry, hairless area of skin behind the ear, taking care to avoid any cuts or irritation (see "Instructions for use"). Application of one Scopoderm Patch is quite sufficient to ensure protection for up to 72 hours. Should protection be required for longer periods of time, the Scopoderm Patch must be removed after 72 hours and a fresh system applied behind the other ear. (No more than one system should be used at a time). Conversely, if protection is only required for a shorter period of time, the system should be removed at the end of the journey.
To prevent traces of active substance from entering the eyes - which might lead to slight temporary blurring of vision and to dilatation of the pupils (sometimes in one eye only) - patients should wash their hands thoroughly after handling the system. In addition, after removal of the system, the site of application should also be washed. These precautions are necessary to minimise any chance of hyoscine accidentally being transferred to the eyes (see side-effects).
Limited contact with water (i.e. during bathing or swimming), should not affect the system, although it should be kept as dry as possible.
If the Scopoderm Patch, which normally adheres well to the skin, becomes accidentally detached, it should be replaced by a fresh system.
Use in Elderly
Scopoderm Patch may be used in the elderly (see dosage recommendations for adults) although the elderly may be more prone to suffer from the side-effects of hyoscine (see Warnings and precautions).
Hepatic and renal impairment
Scopoderm Patch should only be used with caution in patients with impaired hepatic or renal function (see Warnings and Precautions).
Paediatric population
Scopoderm Patch can be used in children aged 10 years or over (see dosage recommendations for adults). The safety and efficacy of Scopoderm Patch for children younger than 10 years have not been established.
Route of Administration
Transdermal
Method of administration
Tear open the sachet at the top and take out the flesh-coloured system complete with its transparent hexagonal protective foil (Fig. 1).
Holding the system only by its edge – and taking care, if possible, not to touch the silvery adhesive side (Fig. 2) - peel off the hexagonal foil.
Press the system (silvery adhesive side downwards) firmly on to a clean, dry, hairless area of skin behind the ear (Fig. 3).
Once the system has been affixed, it should not be touched again while it is being worn, since pressure exerted on it might possibly cause scopolamine to ooze out at the edge.
After the system has been either applied or removed, the hand (and, after its removal, also the site of application) should be thoroughly washed.
Do not cut the patch. Dispose of used patches carefully.
4.3. Contraindications
Scopoderm Patch is contra-indicated in patients with glaucoma or with a history of the condition, and in patients with known hypersensitivity to hyoscine or to any of the excipients listed in section 6.1.
4.4. Special warnings and precautions for use
Scopoderm Patch should be used with caution in patients with pyloric stenosis or those who have difficulty in passing water owing to an impeded flow of urine (e.g. in diseases of the prostate), as well as in patients with intestinal obstruction.
Patients should not consume alcohol whilst using Scopoderm Patch.
Scopoderm Patch should also be used with caution in elderly patients, and in patients with impaired hepatic or renal function.
In patients whose case history indicates that there might be raised intra-ocular pressure (pressure pain, blurred vision, glaucomatous halo), Scopoderm Patch should only be employed after an ophthalmological examination.
In rare cases, confusional states and visual hallucinations may occur. In such cases, Scopoderm Patch should be removed immediately. If severe symptoms persist in a severe form, appropriate therapeutic measures should be taken e.g. administration of physostigmine, 1-4 mg (in children 0.5 mg), to be repeated if necessary (see overdose section).
Idiosyncratic reactions may occur with ordinary therapeutic doses of hyoscine.
In isolated cases an increase in seizure frequency in epileptic patients has been reported.
Care should be taken after removal of the system as side-effects may persist for up to 24 hours or longer.
Due the presence of aluminium in one of the layers of the system, the patch should be removed before medical scans.
After applying, removing, or handling the Scopoderm Patch hands and application site should be thoroughly washed.
Do not cut the patch. Dispose of used patches carefully. Do not apply more than one patch at a time.
4.5. Interaction with other medicinal products and other forms of interaction
Scopoderm Patch should be used with caution in patients being treated with drugs that act on the central nervous system. This applies particularly to patients under treatment with drugs displaying anticholinergic activity e.g. other belladonna alkaloids, antihistamines, tricyclic antidepressants (such as amitriptyline and imipramine), amantadine, quinidine.
Patients should refrain from consuming alcohol during use of Scopoderm Patch.
4.6. Fertility, pregnancy and lactation
Teratogenic studies have been performed in pregnant rats and rabbits with hyoscine administered by daily intravenous injection. No adverse effects were noted in rats. In rabbits, the drug had a marginal embryotoxic effect at a high dose (at drug plasma levels approximately 100 times those observed in humans using Scopoderm Patch).
Scopoderm Patch should only be used during pregnancy if the expected benefits to the mother outweigh the potential risks to the foetus.
If pregnant, the patient should talk to a doctor before using Scopoderm Patch.
As scopolamine is excreted in human milk, although only in trace amounts, caution should be exercised when Scopoderm Patch is administered to a nursing woman. If breast-feeding, the patient should talk to a doctor before using Scopoderm Patch.
4.7. Effects on ability to drive and use machines
Scopoderm may cause drowsiness, dizziness, confusion, or visual disturbance in certain individuals. Patients using the system must not drive, operate machinery, pilot an aircraft, dive, or engage in any other activities in which such symptoms could be dangerous (see side-effects).
4.8. Undesirable effects
Adverse reactions are listed below by system organ class and frequency.
Frequencies are defined as: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), or not known (cannot to be estimated from available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
MedDRA SOC
Adverse Reaction
Frequency
Psychiatric disorders
disorientation, confusion and hallucinations.
Rare
Nervous system disorders
somnolence, dizziness
Very Common
memory impairment, disturbance in attention, restlessness, disorientation, confusion and visual hallucinations. (see precautions).
Rare
agitation, coordination, abnormalities, headache
Not Known
Eye disorders
disturbances of visual accommodation (cycloplegia) including blurred vision, myopia and mydriasis (sometimes unilateral)
Very Common
eyelid irritation
Common
pupillary dilatation may precipitate acute glaucoma, particularly narrow angle glaucoma (see Contra-Indications).
Very Rare
Gastrointestinal disorders
dryness of the mouth.
Very Common
General disorders and administration site conditions
hyperthermia
Not Known
Skin and subcutaneous tissue disorders
skin irritation
Common
rash generalised
Very Rare
application site reactions including rash, pruritus, erythema and burning
Not Known
Renal and urinary disorders
urinary retention
Rare
Side-effects after removal of Scopoderm Patch
After discontinuation of treatment, in rare cases - usually after several days of use - symptoms such as dizziness, nausea, vomiting, headache, and disturbances of balance have been reported. In such cases, patients should not drive or engage in other activities requiring concentration (see warnings and precautions).
Reporting of suspected adverse reactions
Reporting of suspect adverse reactions after authorisation of the medical product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the Yellow Card Scheme, www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
Symptoms
The central actions of scopolamine in high doses are similar to those of atropine. Initially, restlessness, excitation and confusion may be observed. In response to higher doses, delirium, hallucinations and convulsions set in. At very high doses, coma and respiratory paralysis may occur.
Management
If symptoms of overdosage occur, the system(s) should be removed immediately as some overdose symptoms may persist for up to 24 hours or longer even after patch removal. Physostigmine is the most effective antidote.
Depending on the severity of poisoning, physostigmine should be given by slow intravenous injection in doses of 1-4mg (0.5mg in children). Repeated injections may be necessary since physostigmine is rapidly metabolised the patient may lapse into coma again within 1-2 hours, thus necessitating renewed injections. Diazepam may be used to counter excitation and convulsions although at higher doses it may cause respiratory depression. In severe cases, artificial respiration may be necessary. If hyperthermia occurs, immediate action should be taken to dissipate heat (cold baths).
🇵🇱 Known in Poland as
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Hyoscine. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
- Buscolysin partial — not the same combinationHyoscini butylbromidum · injection / infusion
- Buscopan partial — not the same combinationHyoscini butylbromidum · taken by mouth
- Scopolan partial — not the same combinationHyoscini butylbromidum · rectal / vaginal
- Buscopan forte partial — not the same combinationHyoscini butylbromidum · taken by mouth
- AuroGastro partial — not the same combinationHyoscini butylbromidum · taken by mouth
- Scopolamine butylbromide Kalceks partial — not the same combinationHyoscini butylbromidum · injection / infusion
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
💬 Ask about this leaflet
Ask anything about Scopoderm 1.5mg Patch. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.